Key facts
- This page summarizes Andrew D. Jones's Form 4 filing for NovaBay Pharmaceuticals, Inc. (NBY).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 06 Dec 2021, 15:30.
Andrew D. Jones - 03 Dec 2021 Form 4 Insider Report for NovaBay Pharmaceuticals, Inc. (NBY)
- Reporting relationship
- CFO
- Issuer ticker
- NBY
- Reported as of
- 03 Dec 2021
- Net transaction value
- +$20,000
- SEC form
- 4
- Accepted by SEC
- 06 Dec 2021, 15:30:48 UTC
- Prior SEC filing
- 07 May 2021
- Next SEC filing
- 17 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Andrew D. Jones
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Andrew D. Jones filed Form 4 for NovaBay Pharmaceuticals, Inc. (NBY) on 06 Dec 2021.
Change
- Previous filing in this sequence was filed on 07 May 2021.
- Current net transaction value: +$20,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NBY
transaction
Common Stock
Purchase
- Transaction value
- $3,824
- Shares
- +8,690
- Change %
- +11%
- Price
- $0.4400
- Shares after
- 90,696
- Date
- 03 Dec 2021
- Ownership
- Direct
NBY
transaction
Common Stock
Purchase
- Transaction value
- $16,177
- Shares
- +36,765
- Change %
- +41%
- Price
- $0.4400
- Shares after
- 127,461
- Date
- 06 Dec 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.